These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2968376)

  • 61. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
    Whitley RJ; Weiss H; Gnann JW; Tyring S; Mertz GJ; Pappas PG; Schleupner CJ; Hayden F; Wolf J; Soong SJ
    Ann Intern Med; 1996 Sep; 125(5):376-83. PubMed ID: 8702088
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Severe but reversible neurotoxicity from acyclovir.
    Cohen SM; Minkove JA; Zebley JW; Mulholland JH
    Ann Intern Med; 1984 Jun; 100(6):920. PubMed ID: 6721312
    [No Abstract]   [Full Text] [Related]  

  • 63. Oral Acyclovir in the Treatment of Verruca.
    Bagwell A; Loy A; McFarland MS; Tessmer-Neubauer A
    J Drugs Dermatol; 2016 Feb; 15(2):237-8. PubMed ID: 26885794
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vesicular eruption. A local complication of concentrated acyclovir infusions.
    Sylvester RK; Ogden WB; Draxler CA; Lewis FB
    JAMA; 1986 Jan; 255(3):385-6. PubMed ID: 3510331
    [No Abstract]   [Full Text] [Related]  

  • 65. [Acyclovir nephrotoxicity].
    Briso-Montiano JM; Hernández E; Escudero E; Mendiluce A; Sánchez L; Miyar V
    An Med Interna; 1995 Oct; 12(10):501-2. PubMed ID: 8519942
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Zoster should be treated with peroral acyclovir].
    Molin L
    Lakartidningen; 1991 Jun; 88(26-27):2381-2. PubMed ID: 1857160
    [No Abstract]   [Full Text] [Related]  

  • 67. Risk of acute kidney injury from oral acyclovir: a population-based study.
    Lam NN; Weir MA; Yao Z; Blake PG; Beyea MM; Gomes T; Gandhi S; Mamdani M; Wald R; Parikh CR; Hackam DG; Garg AX
    Am J Kidney Dis; 2013 May; 61(5):723-9. PubMed ID: 23312723
    [TBL] [Abstract][Full Text] [Related]  

  • 68. More about acyclovir neurotoxicity in patients on haemodialysis.
    Gómez Campderá FJ; Verde E; Vozmediano MC; Valderrábano F
    Nephron; 1998; 78(2):228-9. PubMed ID: 9496746
    [No Abstract]   [Full Text] [Related]  

  • 69. [A patient with thyroid carcinoma who developed consciousness disturbance during acyclovir administration for herpes zoster].
    Matsumoto R; Yoshida T; Tabata K; Nakagawa S; Yanagisawa N
    Rinsho Shinkeigaku; 1996 Apr; 36(4):590-3. PubMed ID: 8810856
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].
    Helldén A; Bergman U; Dwyer R; Medin C; Molanaei H; Ståhle L; Thylén P; Odar-Cederlöf I
    Lakartidningen; 2007 Jun 13-26; 104(24-25):1916-20. PubMed ID: 17674672
    [No Abstract]   [Full Text] [Related]  

  • 71. [Varicella zoster pneumonia. Treatment with orally administered acyclovir].
    Gil Sanz ME; Arribas Blanco JM; López Romero A; González-Baylin ML
    Enferm Infecc Microbiol Clin; 1995 Mar; 13(3):193-4. PubMed ID: 7734507
    [No Abstract]   [Full Text] [Related]  

  • 72. Acyclovir in the treatment of infection due to herpes viruses.
    Zicha J; Stafová J; Vacek V
    Czech Med; 1986; 9(4):203-5. PubMed ID: 3028734
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acyclovir-associated colitis.
    Moshkowitz M; Konikoff FM; Arber N; Baratz M; Gilat T
    Am J Gastroenterol; 1993 Dec; 88(12):2110-1. PubMed ID: 8249983
    [No Abstract]   [Full Text] [Related]  

  • 74. [Current developments in antiviral chemotherapy. 2: Acyclovir].
    Stamminger T; Fleckenstein B
    Fortschr Med; 1994 Apr; 112(11):159-60. PubMed ID: 8200599
    [No Abstract]   [Full Text] [Related]  

  • 75. Acyclovir and other chemotherapy for herpes group viral infections.
    Balfour HH
    Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent developments in the management of herpes zoster (shingles).
    Wood MJ; McKendrick M; McGill JI
    Chemioterapia; 1987 Jun; 6(2 Suppl):671-3. PubMed ID: 3334658
    [No Abstract]   [Full Text] [Related]  

  • 77. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.
    Selby PJ; Powles RL; Easton D; Perren TJ; Stolle K; Jameson B; Fiddian AP; Tryhorn Y; Stern H
    Br J Cancer; 1989 Mar; 59(3):434-8. PubMed ID: 2539180
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peripheral edema and oral acyclovir.
    Hisler BM; Daneshvar SA; Aronson PJ; Hashimoto K
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1142-3. PubMed ID: 2968376
    [No Abstract]   [Full Text] [Related]  

  • 79. Which term should be used to describe drug eruptions confined to sites of previous herpes zoster lesions, 'isotopic response' or 'recall phenomenon'?
    Mizukawa Y; Shiohara T
    Clin Exp Dermatol; 2004 May; 29(3):323; author reply 324. PubMed ID: 15115529
    [No Abstract]   [Full Text] [Related]  

  • 80. Drug eruption secondary to aciclovir with recall phenomenon in a dermatome previously affected by herpes zoster.
    Carrasco L; Pastor MA; Izquierdo MJ; Fariña MC; Martín L; Fortes J; Requena L
    Clin Exp Dermatol; 2002 Mar; 27(2):132-4. PubMed ID: 11952706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.